SYN®-TACKS offers for the first time the possibility to interact with the most relevant protein structures of the dermal-epidermal junction (DEJ): laminin V, collagen type IV, VII and XVII and integrin. SYN®-TACKS improves skin tonicity by 32% in two months and has been shown to improve cellular cohesion up to 23%.
For more information please submit your request.
Leading peptide manufacturer DSM conducts in-depth insights research to deliver globally relevant cosmetic solutions through its peptide innovation platform
DSM in personal care is meeting anticipated consumer demand for skin protection against pollution with a concept featuring five of its leading actives